| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |